Lycera Corp. (Lycera)

Oncology Corporate Profile

HQ Location

2800 Plymouth Rd. NCRC, Building 26
Ann Arbor, MI 48109

Company Description

Lycera is a biopharmaceutical company developing novel oral immune modulators for the treatment of autoimmune diseases and cancer. Based on successful progress of its world-class R&D platform, including expertise in immune metabolism, cell signaling, and immune cell differentiation.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
LYC-30937RORy agonistVarious cancer typesPreclinicalCelgene

View additional information on product candidates here »


Recent News Headlines

There are no news items to display